![Chandra Paul Leo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chandra Paul Leo
Director/Board Member at
MONTE ROSA THERAPEUTICS, INC.
Net worth: 242 000 $ as of 30/06/2026
Profile
Chandra Paul Leo currently works at Gynesonics, Inc., as Director, i-Optics BV, as Director, Galecto Biotech ApS, as Director from 2018, Fore Biotherapeutics, Inc., as Director, Dren Bio, Inc., as Director, Monte Rosa Therapeutics, Inc., as Independent Director from 2020, River 2 Renal Corp., as Director, River 3 Renal Corp., as Director, and HBM Partners AG, as Investment Advisor Private Equity from 2007.
Dr. Leo also formerly worked at Cell Medica Switzerland AG, as Vice Chairman, ChemoCentryx, Inc., as Director, Symbiomix Therapeutics LLC, as Director, ESBATech, a Novartis Co. GmbH, as Director, CardiacAssist, Inc., as Director, ObsEva SA, as Director, Homology Medicines, Inc., as Director, Damora Therapeutics, Inc., as Director, Longboard Pharmaceuticals, Inc., as Director, and Wellington Partners GmbH, as Principal.
Dr. Leo received his Masters Business Admin degree from INSEAD, graduate degree from the University of Basel, and doctorate degree from Freie Universität Berlin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/03/2025 | 10,000 ( 0.01% ) | 242 000 $ | 30/06/2026 |
Chandra Paul Leo active positions
| Companies | Position | Start |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Director/Board Member | 01/09/2020 |
River 2 Renal Corp.
 River 2 Renal Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapies targeting orphan diseases in the renal space | Director/Board Member | - |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Director/Board Member | - |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Director/Board Member | - |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Private Equity Analyst | 01/01/2007 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Director/Board Member | 26/10/2018 |
i-Optics BV
 i-Optics BV Medical SpecialtiesHealth Technology Develops and produces eye diagnosis and therapeutic solutions | Director/Board Member | - |
Gynesonics, Inc.
 Gynesonics, Inc. Medical SpecialtiesHealth Technology Develops medical devices for diagnostic intrauterine imaging and trans cervical treatment of symptomatic uterine fibroids | Director/Board Member | - |
River 3 Renal Corp.
 River 3 Renal Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug development company for treating kidney diseases | Director/Board Member | - |
Former positions of Chandra Paul Leo
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Chandra Paul Leo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
44
1st degree connections
22
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 22 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Gynesonics, Inc.
Gynesonics, Inc. Medical SpecialtiesHealth Technology Develops medical devices for diagnostic intrauterine imaging and trans cervical treatment of symptomatic uterine fibroids | Health Technology |
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Health Technology |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Finance |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Commercial Services |
CardiacAssist, Inc.
 CardiacAssist, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
i-Optics BV
i-Optics BV Medical SpecialtiesHealth Technology Develops and produces eye diagnosis and therapeutic solutions | Health Technology |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and distributes pharmaceutical, biological, medical, and diagnostic products | Health Technology |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
River 2 Renal Corp.
River 2 Renal Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapies targeting orphan diseases in the renal space | Health Technology |
River 3 Renal Corp.
River 3 Renal Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug development company for treating kidney diseases | Health Technology |
- Stock Market
- Insiders
- Chandra Paul Leo
